Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
S Koirala, Sergey E. Borisov, Edvardas Danila, Andrei Mariandyshev et autres
The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively evaluate the effectiveness of bedaquiline (and/or delamanid)- containing regimens in a large cohort of consecutive TB patients …
bd, ru, lt, jp, pk, br, np, lv, pe, by, au, it, Maroc, se, nz, bg, Niger, be, nl, cn, in, ar, mx, us, kw, gr, es, gb, ch, vn, ro, Ouganda, pt, mn, py, sk, Eswatini, Afrique du Sud, Zimbabwe, dk (code pays fourni par la source)